PMID- 30916121 OWN - NLM STAT- MEDLINE DCOM- 20190612 LR - 20200309 IS - 1678-9741 (Electronic) IS - 0102-7638 (Print) IS - 0102-7638 (Linking) VI - 34 IP - 2 DP - 2019 Mar-Apr TI - Benefits of Fasting Abbreviation with Carbohydrates and Omega-3 Infusion During CABG: a Double-Blind Controlled Randomized Trial. PG - 125-135 LID - S0102-76382019000200004 [pii] LID - 10.21470/1678-9741-2018-0336 [doi] AB - OBJECTIVE: To assess postoperative clinical data considering the association of preoperative fasting with carbohydrate (CHO) loading and intraoperative infusion of omega-3 polyunsaturated fatty acids (omega-3 PUFA). METHODS: 57 patients undergoing coronary artery bypass grafting (CABG) were randomly assigned to receive 12.5% maltodextrin (200 mL, 2 h before anesthesia), (CHO, n=14); water (200 mL, 2 h before anesthesia), (control, n=14); 12.5% maltodextrin (200 mL, 2 h before anesthesia) plus intraoperative infusion of omega-3 PUFA (0.2 g/kg), (CHO+W3, n=15); or water (200 mL, 2 h before anesthesia) plus intraoperative infusion of omega-3 PUFA (0.2 g/kg), (W3, n=14). The need for vasoactive drugs was analyzed, in addition to postoperative inflammation and metabolic control. RESULTS: There were two deaths (3.5%). Patients in CHO groups presented a lower incidence of hospital infection (RR=0.29, 95% CI 0.09-0.94; P=0.023), needed fewer vasoactive drugs during surgery and ICU stay (P<0.05); and had better blood glucose levels in the first six hours of recovery (P=0.015), requiring less exogenous insulin (P=0.018). Incidence of postoperative atrial fibrillation (POAF) varied significantly among groups (P=0.009). Subjects who receive omega-3 PUFA groups had fewer occurrences of POAF (RR=4.83, 95% CI 1.56-15.02; P=0.001). Patients in the W3 group had lower ultrasensitive-CRP levels at 36 h postoperatively (P=0.008). Interleukin-10 levels varied among groups (P=0.013), with the highest levels observed in the postoperative of patients who received intraoperative infusion of omega-3 PUFA (P=0.049). CONCLUSION: Fasting abbreviation with carbohydrate loading and intraoperative infusion of omega-3 PUFA is safe and supports faster postoperative recovery in patients undergoing on-pump CABG. FAU - Feguri, Gibran Roder AU - Feguri GR AUID- ORCID: 0000-0002-1132-9667 AD - Department of Cardiology and Cardiovascular Surgery, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Lima, Paulo Ruiz Lucio de AU - Lima PRL AD - Department of Cardiology and Cardiovascular Surgery, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Franco, Anna Carolina AU - Franco AC AD - Department of Cardiovascular Surgery, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Cruz, Felipe Ramos Honorato De La AU - Cruz FRH AD - Department of Cardiovascular Surgery, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Borges, Danilo Cerqueira AU - Borges DC AD - Department of Cardiology and Cardiovascular Surgery, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Toledo, Laura Ramos AU - Toledo LR AD - Department of Physical Therapy, Hospital Geral Universitario, Universidade de Cuiaba (HGU-UNIC), Cuiaba, MT, Brazil. FAU - Segri, Neuber Jose AU - Segri NJ AD - Department of Statistics, Universidade Federal do Mato Grosso (UFMT), Cuiaba, MT, Brazil. FAU - Aguilar-Nascimento, Jose Eduardo de AU - Aguilar-Nascimento JE AD - Universidade Federal do Mato Grosso (UFMT), Cuiaba, MT, Brazil. AD - Universidade de Varzea Grande (UNIVAG), Varzea Grande, MT, Brazil. LA - eng PT - Journal Article PT - Randomized Controlled Trial PL - Brazil TA - Braz J Cardiovasc Surg JT - Brazilian journal of cardiovascular surgery JID - 101677045 RN - 0 (Blood Glucose) RN - 0 (Dietary Carbohydrates) RN - 0 (Fatty Acids, Omega-3) SB - IM MH - Aged MH - Analysis of Variance MH - Blood Glucose/analysis MH - Coronary Artery Bypass/*methods/rehabilitation MH - Dietary Carbohydrates/*administration & dosage MH - Double-Blind Method MH - *Fasting MH - Fatty Acids, Omega-3/*administration & dosage MH - Female MH - Humans MH - Insulin Resistance MH - Length of Stay MH - Male MH - Middle Aged MH - Perioperative Period MH - Postoperative Complications/prevention & control MH - Prospective Studies MH - Reference Values MH - Reproducibility of Results MH - Statistics, Nonparametric MH - Time Factors MH - Treatment Outcome PMC - PMC6436776 COIS- No conflict of interest. EDAT- 2019/03/28 06:00 MHDA- 2019/06/14 06:00 PMCR- 2019/03/01 CRDT- 2019/03/28 06:00 PHST- 2018/10/22 00:00 [received] PHST- 2018/10/31 00:00 [accepted] PHST- 2019/03/28 06:00 [entrez] PHST- 2019/03/28 06:00 [pubmed] PHST- 2019/06/14 06:00 [medline] PHST- 2019/03/01 00:00 [pmc-release] AID - S0102-76382019000200004 [pii] AID - 10.21470/1678-9741-2018-0336 [doi] PST - ppublish SO - Braz J Cardiovasc Surg. 2019 Mar-Apr;34(2):125-135. doi: 10.21470/1678-9741-2018-0336.